trial · primary record
Ivonescimab Combined With Chemotherapy
Malignant Pleural Mesothelioma, Advanced
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 9 |
| Primary completion | 2028-11-30 |
| Primary endpoint | Dose-Limiting Toxicities |
| Registry ID | NCT07885306 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:25.091Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07885306
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Ivonescimab Combined With Chemotherapy · compound